Circulating-tumor DNA as predictor of enzalutamide response post-abiraterone treatment in metastatic castration-resistant prostate cancer
- Resource Type
- Article
- Source
- In
Cancer Treatment and Research Communications 2020 24 - Subject
- Language
- ISSN
- 2468-2942